Anaesthesia, movement and emesis.
One hundred and eighty-two women undergoing dilatation and curettage were allocated randomly to receive premedication comprising temazepam, papaveretum-hyoscine or placebo. The temazepam recipients reported significantly fewer episodes of postoperative nausea. Movement was blamed by 66% of patients who identified a cause for nausea. These patients had higher scores on a motion sickness susceptibility questionnaire and were more likely to have been treated previously for nausea or vomiting. It may be possible to identify susceptible patients before surgery.
Kamath
B
B
Department of Anaesthesia, City Hospital and Queen's Medical Centre, Nottingham.
Curran
J
J
Hawkey
C
C
Beattie
A
A
Gorbutt
N
N
Guiblin
H
H
Kong
A
A
D000328:Adult; D004198:Disease Susceptibility; D005260:Female; D006801:Humans; D009041:Motion Sickness / Q000209:etiology; D009068:Movement / Q000502:physiology*; D009325:Nausea / Q000139:chemically induced* / Q000517:prevention & control; D009892:Opium; D011229:Preanesthetic Medication / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D012601:Scopolamine; D013693:Temazepam; D014839:Vomiting / Q000139:chemically induced* / Q000517:prevention & control
D009892:Opium; D013693:Temazepam; D012601:Scopolamine